Skip to main content

Table 2 Five and 10-year lung cancer related, other cancer related and non-cancer related death probability

From: A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

Characteristics

Lung cancer related death probability

Other cancer related death probability

Non-cancer related death probability

5 Year

10 Year

P

5 Year

10 Year

P

5 Year

10 Year

P

(%)

(%)

 

(%)

(%)

 

(%)

(%)

 

Diagnostic Age, years

  

< 0.001

  

0.159

  

< 0.001

 < 45

28.1

36.9

 

0.4

0.4

 

4.5

8.2

 

 45–64

31.7

39.6

 

1.4

1.6

 

7.3

14.2

 

 65–74

33.6

41.4

 

1.2

1.9

 

12.3

23.3

 

 ≥ 75

37.0

44.3

 

1.4

1.7

 

19.6

34.2

 

Gender

  

< 0.001

  

0.146

  

< 0.001

 Female

29.9

38.7

 

1.2

1.7

 

9.8

19.3

 

 Male

37.3

44.1

 

1.4

1.7

 

14.2

24.9

 

Ethnicity

  

< 0.001

  

< 0.001

  

< 0.001

 White

33.8

41.5

 

1.3

1.7

 

12.4

22.7

 

 Asian

31.2

41.4

 

0.8

1.2

 

8.5

16.1

 

 Black

34.2

40.8

 

2.0

2.2

 

10.8

20.4

 

 Others/Unknown

23.7

24.8

 

0.3

0.3

 

9.8

36.1

 

Primary tumor location

  

0.09

  

0.676

  

0.097

 Left-sided

34.1

41.9

 

1.3

1.7

 

12.2

23.2

 

 Right-sided

33.3

41.0

 

1.3

1.7

 

11.9

21.4

 

Anatomic sites

  

< 0.001

  

0.45

  

0.032

 Upper

31.9

39.2

 

1.3

1.7

 

12.0

23.1

 

 Middle

33.6

41.5

 

1.2

1.5

 

11.7

18.9

 

 Lower

35.2

44.0

 

1.2

1.7

 

12.4

21.4

 

 Bronchus/Others

47.3

53.2

 

1.7

1.9

 

10.8

16.6

 

Histologic subtype

  

< 0.001

  

0.04

  

< 0.001

 ADC

33.4

42.2

 

1.3

1.7

 

10.3

19.6

 

 SCC

35.2

40.9

 

1.3

1.6

 

16.6

29.1

 

 BAC

23.8

33.8

 

0.8

1.5

 

8.4

16.2

 

 ADSC

41.7

48.7

 

1.6

1.7

 

12.7

21.8

 

 LCC

43.7

49.8

 

2.1

2.3

 

13.1

20.6

 

 Other

29.0

40.6

 

1.1

1.1

 

7.2

17.9

 

 Unspecified

41.4

45.6

 

1.9

2.2

 

11.3

20.1

 

Differentiation

  

< 0.001

  

< 0.001

  

< 0.001

 Well

17.3

26.5

 

0.7

1.2

 

9.1

20.5

 

 Moderately

31.5

40.2

 

1.1

1.6

 

12.8

22.4

 

 Poorly

40.7

47.0

 

1.6

1.9

 

12.1

22.1

 

 Undifferentiated

41.3

47.8

 

1.9

2.1

 

12.8

21.2

 

Clinical stage

  

< 0.001

  

< 0.001

  

< 0.001

 I

22.0

30.0

 

1.0

1.4

 

13.1

25.7

 

 II

46.5

53.1

 

1.5

1.9

 

11.8

18.7

 

 III

53.5

61.1

 

1.8

2.2

 

9.7

16.1

 

 IV

62.8

71.3

 

2.6

2.6

 

8.4

11.9

 

Tumor size, cm

  

< 0.001

  

< 0.001

  

< 0.001

 ≤ 1.0

18.4

27.4

 

0.8

1.9

 

8.8

18.3

 

 1.1 to 3.0

26.2

34.5

 

1.1

1.6

 

12.3

23.8

 

 3.1 to 5.0

39.6

47.2

 

1.5

1.7

 

12.8

22.6

 

 5.1 to 7.0

47.6

53.8

 

1.5

1.9

 

11.0

17.9

 

 > 7.1

57.6

62.1

 

1.8

2.5

 

10.2

15.6

 

Tumor extent

  

< 0.001

  

< 0.001

  

< 0.001

 Local

28.0

35.9

 

1.1

1.5

 

12.5

23.8

 

 Regional

60.3

65.9

 

2.0

2.7

 

13.1

16.9

 

 Distant

43.8

51.3

 

1.6

2.0

 

11.0

19.1

 

Lymph node stage

  

< 0.001

  

< 0.001

  

< 0.001

 N0

25.2

33.2

 

1.1

1.5

 

12.9

25.0

 

 N1

49.6

56.7

 

1.5

2.0

 

10.9

16.6

 

 N2/N3

59.0

66.3

 

1.9

2.2

 

8.8

14.0

 

Examined lymph node

  

< 0.001

  

0.379

  

< 0.001

 < 5

34.5

42.7

 

1.5

1.9

 

13.2

24.7

 

 5 to 9

32.5

40.1

 

1.1

1.6

 

12.0

22.0

 

 10 to 14

32.8

40.2

 

1.2

1.6

 

11.5

21.8

 

 15 to 20

34.0

42.1

 

1.3

1.5

 

10.5

18.7

 

 ≥ 20

36.2

43.0

 

1.4

1.7

 

11.4

18.3

 

Positive lymph node

  

< 0.001

  

< 0.001

  

< 0.001

 0

25.7

33.5

 

1.1

1.5

 

12.8

24.9

 

 1

49.6

56.8

 

1.9

2.4

 

10.5

17.0

 

 2

52.3

59.9

 

1.6

1.7

 

10.2

15.3

 

 3

55.6

63.7

 

1.4

2.0

 

10.4

14.9

 

 ≥ 4

63.7

70.9

 

1.8

1.9

 

8.8

11.4

 

Type of surgery

  

< 0.001

  

0.249

  

< 0.001

 Lobectomy

32.0

39.7

 

1.2

1.7

 

11.8

22.0

 

 Pneumonectomy

51.0

57.6

 

1.7

1.8

 

11.5

17.4

 

 Sub-lobar

35.7

43.9

 

1.3

1.8

 

14.4

26.7

 

Chemotherapy

  

< 0.001

  

0.214

  

< 0.001

 None

28.2

35.5

 

1.2

1.7

 

14.0

26.1

 

 Yes

46.4

54.9

 

1.4

1.8

 

7.3

13.0

 

Radiotherapy

  

< 0.001

  

< 0.001

  

< 0.001

 None

30.0

37.7

 

1.2

1.6

 

12.5

23.3

 

 Yes

56.9

64.3

 

1.9

2.1

 

8.8

14.8

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us